SBI Securities’s Sunshine Biopharma SBFM Stock Holding History

SBI Securities’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340	Sell	162 -21	-11%	-$135	﹤0.01%	3164
2026 Q1	$1.91K	Sell	183 -302	-62%	-$3.56K	﹤0.01%	2433
2025 Q4	$5.96K	Hold	485	–	–	﹤0.01%	1956
2025 Q3	$7.23K	Sell	485 -184	-28%	-$2.73K	﹤0.01%	1904
2025 Q2	$9.64K	Buy	669 +147	+28%	+$2.15K	﹤0.01%	1722
2025 Q1	$9.98K	Buy	522 +451	+635%	+$11.3K	﹤0.01%	1609
2024 Q4	$2.13K	Buy	+71	New	+$2.02K	﹤0.01%	2291

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SFG

Strive Financial Group Carmel, Indiana $230M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

SBI Securities's SBFM Position: Q2 2026 in Review

SBI Securities reduced its Sunshine Biopharma (SBFM) stake by 11% in Q2 2026, selling an estimated $135 and leaving 162 shares worth $340. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

SBI Securities first reported a position in SBFM in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.98K in Q1 2025. 9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

SBI Securities held 162 shares of Sunshine Biopharma worth $340 as of Q2 2026.
SBI Securities sold 21 Sunshine Biopharma shares in Q2 2026, an estimated $135.
Sunshine Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3164 holding.
SBI Securities first reported a position in Sunshine Biopharma in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Sunshine Biopharma position peaked at $9.98K in Q1 2025.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.